Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
SHMT2 encodes the mitochondrial form of a pyridoxal phosphate-dependent enzyme that catalyzes the reversible reaction of serine and tetrahydrofolate to glycine and 5,10-methylene tetrahydrofolate. Zusätzlich bieten wir Ihnen SHMT2 Antikörper (38) und und viele weitere Produktgruppen zu diesem Protein an.
Showing 8 out of 9 products:
The one-carbon donor formate generally rescues cells from SHMT (zeige SHMT1 Proteine) inhibition, but paradoxically increases the inhibitor's cytotoxicity in diffuse large B-cell lymphoma (DLBCL); this effect is rooted in defective glycine uptake in DLBCL cell lines, rendering them uniquely dependent upon SHMT (zeige SHMT1 Proteine) enzymatic activity to meet glycine demand.
Our data confirm the heterogeneity of breast tumors at a functional proteomic level and dissects the relationship between metabolism-related proteins, pathological features and patient survival. These observations highlight the importance of SHMT2 and ASCT2 (zeige SLC1A5 Proteine) as valuable individual prognostic markers and potential targets for personalized breast cancer therapy
Data suggest that serine hydroxymethyltransferase 2 (SHMT2) may be a potential target in the treatment of hepatocellular carcinoma (HCC (zeige FAM126A Proteine)).
High SHMT2 expression is associated with idiopathic pulmonary fibrosis.
Site-directed mutagenesis experiments on SHMT1 (zeige SHMT1 Proteine) demonstrate that selective enzyme inhibition relies on the presence of a cysteine residue at the active site of SHMT1 (zeige SHMT1 Proteine) (Cys204) that is absent in SHMT2.
These results indicate that SHMT2 may be a valuable prognostic biomarker in ER-negative breast cancer cases
our results for the first time showed that miR (zeige MLXIP Proteine)-615-5p prevents proliferation and migration through negatively regulating SHMT2 in HCC (zeige FAM126A Proteine).
The SHMT-2 is the direct targets of miR (zeige MLXIP Proteine)-370 and miR (zeige MLXIP Proteine)-373, respectively, in human articular chondrocytes.
High SHMT2 expression increases glycine-dependent nucleotide synthesis leading to bladder cancer growth.
SHMT2 is required for glioblastoma multiforme cells to adapt to the tumour environment, but also renders these cells sensitive to glycine cleavage system inhibition
SHMT1 (zeige SHMT1 Proteine) and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis
This gene encodes the mitochondrial form of a pyridoxal phosphate-dependent enzyme that catalyzes the reversible reaction of serine and tetrahydrofolate to glycine and 5,10-methylene tetrahydrofolate. The encoded product is primarily responsible for glycine synthesis. The activity of the encoded protein has been suggested to be the primary source of intracellular glycine. The gene which encodes the cytosolic form of this enzyme is located on chromosome 17. Alternative splicing results in multiple transcript variants.
, glycine auxotroph A, human complement for hamster
, glycine hydroxymethyltransferase
, serine aldolase
, serine hydroxymethylase
, serine hydroxymethyltransferase, mitochondrial
, serine methylase
, threonine aldolase
, serine hydroxymethyltransferase 2 (mitochondrial)
, mitochondrial serine hydroxymethyltransferase
, Glycine hydroxymethyltransferase
, Serine methylase